1068 related articles for article (PubMed ID: 29782316)
1. From Subjective Cognitive Decline to Alzheimer's Disease: The Predictive Role of Neuropsychological Assessment, Personality Traits, and Cognitive Reserve. A 7-Year Follow-Up Study.
Bessi V; Mazzeo S; Padiglioni S; Piccini C; Nacmias B; Sorbi S; Bracco L
J Alzheimers Dis; 2018; 63(4):1523-1535. PubMed ID: 29782316
[TBL] [Abstract][Full Text] [Related]
2. PER2 C111G polymorphism, cognitive reserve and cognition in subjective cognitive decline and mild cognitive impairment: a 10-year follow-up study.
Bessi V; Giacomucci G; Mazzeo S; Bagnoli S; Padiglioni S; Balestrini J; Tomaiuolo G; Piaceri I; Carraro M; Bracco L; Sorbi S; Nacmias B
Eur J Neurol; 2021 Jan; 28(1):56-65. PubMed ID: 32896064
[TBL] [Abstract][Full Text] [Related]
3. The implication of BDNF Val66Met polymorphism in progression from subjective cognitive decline to mild cognitive impairment and Alzheimer's disease: a 9-year follow-up study.
Bessi V; Mazzeo S; Bagnoli S; Padiglioni S; Carraro M; Piaceri I; Bracco L; Sorbi S; Nacmias B
Eur Arch Psychiatry Clin Neurosci; 2020 Jun; 270(4):471-482. PubMed ID: 31560105
[TBL] [Abstract][Full Text] [Related]
4. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
[TBL] [Abstract][Full Text] [Related]
5. The dual role of cognitive reserve in subjective cognitive decline and mild cognitive impairment: a 7-year follow-up study.
Mazzeo S; Padiglioni S; Bagnoli S; Bracco L; Nacmias B; Sorbi S; Bessi V
J Neurol; 2019 Feb; 266(2):487-497. PubMed ID: 30604054
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
[TBL] [Abstract][Full Text] [Related]
7. Prodromal Dementia with Lewy Bodies and Prodromal Alzheimer's Disease: A Comparison of the Cognitive and Clinical Profiles.
Sadiq D; Whitfield T; Lee L; Stevens T; Costafreda S; Walker Z
J Alzheimers Dis; 2017; 58(2):463-470. PubMed ID: 28453473
[TBL] [Abstract][Full Text] [Related]
8. Hippocampal Volume and Episodic Associative Memory Identify Memory Risk in Subjective Cognitive Decline Individuals in the CIMA-Q Cohort, Regardless of Cognitive Reserve Level and APOE4 Status.
Caillaud M; Maltezos S; Hudon C; Mellah S; ; Belleville S
J Alzheimers Dis; 2023; 94(3):1047-1056. PubMed ID: 37355896
[TBL] [Abstract][Full Text] [Related]
9. Association Between Later Life Lifestyle Factors and Alzheimer's Disease Biomarkers in Non-Demented Individuals: A Longitudinal Descriptive Cohort Study.
Reijs BLR; Vos SJB; Soininen H; Lötjonen J; Koikkalainen J; Pikkarainen M; Hall A; Vanninen R; Liu Y; Herukka SK; Freund-Levi Y; Frisoni GB; Frölich L; Nobili F; Rikkert MO; Spiru L; Tsolaki M; Wallin ÅK; Scheltens P; Verhey F; Visser PJ
J Alzheimers Dis; 2017; 60(4):1387-1395. PubMed ID: 29036813
[TBL] [Abstract][Full Text] [Related]
10. Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study.
Yoon JH; Kim M; Moon SY; Yong SW; Hong JM
J Neurol Sci; 2015 Aug; 355(1-2):174-9. PubMed ID: 26076880
[TBL] [Abstract][Full Text] [Related]
11. Identification of odors, faces, cities and naming of objects in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer´s disease: a longitudinal study.
Tahmasebi R; Zehetmayer S; Pusswald G; Kovacs G; Stögmann E; Lehrner J
Int Psychogeriatr; 2019 Apr; 31(4):537-549. PubMed ID: 30236169
[TBL] [Abstract][Full Text] [Related]
12. Neuropsychological predictors of conversion to probable Alzheimer disease in elderly with mild cognitive impairment.
García-Herranz S; Díaz-Mardomingo MC; Peraita H
J Neuropsychol; 2016 Sep; 10(2):239-55. PubMed ID: 25809316
[TBL] [Abstract][Full Text] [Related]
13. Cognitive, genetic, and brain perfusion factors associated with four year incidence of Alzheimer's disease from mild cognitive impairment.
Alegret M; Cuberas-Borrós G; Espinosa A; Valero S; Hernández I; Ruíz A; Becker JT; Rosende-Roca M; Mauleón A; Sotolongo O; Castell-Conesa J; Roca I; Tárraga L; Boada M
J Alzheimers Dis; 2014; 41(3):739-48. PubMed ID: 24685632
[TBL] [Abstract][Full Text] [Related]
14. Homocysteine - A predictor for five year-mortality in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer's dementia.
Futschek IE; Schernhammer E; Haslacher H; Stögmann E; Lehrner J
Exp Gerontol; 2023 Feb; 172():112045. PubMed ID: 36509298
[TBL] [Abstract][Full Text] [Related]
15. Searching for Primary Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Disease: A Multivariate Follow-Up Study.
López ME; Turrero A; Cuesta P; López-Sanz D; Bruña R; Marcos A; Gil P; Yus M; Barabash A; Cabranes JA; Maestú F; Fernández A
J Alzheimers Dis; 2016 Mar; 52(1):133-43. PubMed ID: 27060953
[TBL] [Abstract][Full Text] [Related]
16. Using Neuropsychological Process Scores to Identify Subtle Cognitive Decline and Predict Progression to Mild Cognitive Impairment.
Thomas KR; Edmonds EC; Eppig J; Salmon DP; Bondi MW;
J Alzheimers Dis; 2018; 64(1):195-204. PubMed ID: 29865077
[TBL] [Abstract][Full Text] [Related]
17. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
Löwe LC; Gaser C; Franke K;
PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E genotypes and plasma levels in mild cognitive impairment conversion to Alzheimer's disease: A follow-up study.
Scarabino D; Broggio E; Gambina G; Maida C; Gaudio MR; Corbo RM
Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1131-1138. PubMed ID: 27604972
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal Fluid Biomarkers and Clinical Progression in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment.
Wolfsgruber S; Polcher A; Koppara A; Kleineidam L; Frölich L; Peters O; Hüll M; Rüther E; Wiltfang J; Maier W; Kornhuber J; Lewczuk P; Jessen F; Wagner M
J Alzheimers Dis; 2017; 58(3):939-950. PubMed ID: 28527210
[TBL] [Abstract][Full Text] [Related]
20. Assessing the effectiveness of subjective cognitive decline plus criteria in predicting the progression to Alzheimer's disease: an 11-year follow-up study.
Mazzeo S; Padiglioni S; Bagnoli S; Carraro M; Piaceri I; Bracco L; Nacmias B; Sorbi S; Bessi V
Eur J Neurol; 2020 May; 27(5):894-899. PubMed ID: 32043740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
